Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Finished Goods (2017 - 2025)

Catheter Precision (VTAK) has disclosed Finished Goods for 9 consecutive years, with $11000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Finished Goods changed N/A to $11000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $11000.0, a N/A change, with the full-year FY2024 number at $15000.0, down 11.76% from a year prior.
  • Finished Goods was $11000.0 for Q3 2025 at Catheter Precision, down from $24000.0 in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $132000.0 in Q1 2021 to a low of $5000.0 in Q4 2021.
  • A 5-year average of $41000.0 and a median of $20500.0 in 2023 define the central range for Finished Goods.
  • Peak YoY movement for Finished Goods: tumbled 94.7% in 2022, then decreased 11.76% in 2024.
  • Catheter Precision's Finished Goods stood at $5000.0 in 2021, then skyrocketed by 40.0% to $7000.0 in 2022, then surged by 142.86% to $17000.0 in 2023, then dropped by 11.76% to $15000.0 in 2024, then fell by 26.67% to $11000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Finished Goods are $11000.0 (Q3 2025), $24000.0 (Q2 2025), and $47000.0 (Q1 2025).